Hookipa Pharma

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$1,290
$36,599
$7,407
$6,867
Gross Profit
576
35,959
6,129
6,380
EBITDA
-21,690
13,015
-16,851
-22,670
EBIT
-22,404
12,375
-18,129
-23,157
Net Income
-19,095
14,383
-24,818
-19,066
Net Change In Cash
1,290
36,599
7,407
6,867
Free Cash Flow
-14,421
-24,272
-11,646
-27,137
Cash
77,150
92,751
117,096
107,676
Basic Shares
12,538
12,597
9,895
11,038

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$20,129
$14,249
$18,448
$19,584
Gross Profit
16,577
14,249
18,448
19,584
EBITDA
-81,376
-69,553
-77,034
-49,135
EBIT
-84,928
-73,155
-81,674
-53,285
Net Income
-81,580
-65,145
-75,666
-33,801
Net Change In Cash
20,129
14,249
18,448
19,584
Cost of Revenue
47,257
-78,832
31,710
Free Cash Flow
-61,683
-25,014
-78,597
-41,710
Cash
117,096
113,444
66,912
143,177
Basic Shares
9,452
6,557
3,289
2,608

Earnings Calls

Quarter EPS
2024-06-30
-$1.52
2024-03-31
$0.11
2023-12-31
-$0.22
2023-09-30
-$0.17